Aviceda Therapeutics logo

Aviceda Therapeutics

Cambridge, MA

Aviceda Therapeutics is a late-stage, pre-clinical stage biotech company focused on the next generation of immuno-modulators by harnessing the power of glycobiology to address the innate immune system and chronic non-resolving inflammation specifically and profoundly.

avicedarx.com

Company Details

Founded

2018

Employees

Between 20 - 100 employees

Raised

$276,810,976

Headquarters Location

Cambridge, MA

Public

No

Acquired

No

CEO

Mohamed GeneadMohamed Genead

Founders

Christopher Scott
Christopher Scott
Mohamed Genead
Mohamed Genead
Derek Kunimoto
Derek Kunimoto
Michael Tolentino
Michael Tolentino

Company Collections

These are collections Aviceda Therapeutics is a part of. Click on the collection name to view similar companies.

Aviceda Therapeutics' Industries

Aviceda Therapeutics Headquarters Location

Broadway 14th Floor, Cambridge, MA 02142

Total Amount Raised: $276,810,976

Aviceda Therapeutics Funding Rounds

  • Series C

    $207,500,000

    Series C Investors

    Omega Fund Management
    TCG Crossover Management
    Catalio Capital Management
    Marshall Wace
    Longitude Capital
    Jeito Capital
    Digitalis Ventures
    Enavate Sciences
    Logos Capital
    Standard Life Aberdeen
    Blue Owl Capital
    OrbiMed Advisors

  • Series Unknown

    $15,610,000

  • Series Unknown

    $49,450,983

  • Series Unknown

    $4,250,000

Funding info provided by Diffbot.

Aviceda Therapeutics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Aviceda Therapeutics.

Recent reviews